Therapeutic approaches for ophthalmic problems in juvenile rheumatoid arthritis

J. M. O'Brien, Daniel Albert

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

Juvenile rheumatoid arthritis is a disease of children which is chronic and painful, with the potential to produce permanent disability and blindness in a significant portion of cases. The treatment we provide these children may also disable them. Managing this disease process and caring for these patients is a challenging task in which therapeutic efficacy must be continually balanced against treatment morbidity. With respect to ocular disease, we must particularly recognize the difficulties parents have in treating a characteristically asymptomatic process with interventions that can produce unpleasant symptomatology. The importance of discussion of therapeutic decisions with parent and child cannot be overemphasized. Children with JRA should be carefully classified and those at greatest risk for development of ocular disease should receive frequent ophthalmologic screening exams. Early intervention and aggressive medical management of intraocular inflammation will minimize morbidity and permanent visual compromise. Patients should also be closely monitored for ocular side effects of therapies directed against articular disease. Procedures employed for treatment of cataract, glaucoma, corneal, and vitreal opacities must take into account the risk and complications of surgical intervention in the JRA patient prone to perioperative inflammation.

Original languageEnglish (US)
Pages (from-to)413-437
Number of pages25
JournalRheumatic Disease Clinics of North America
Volume15
Issue number3
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

Juvenile Arthritis
Eye Diseases
Early Medical Intervention
Therapeutics
Inflammation
Morbidity
Corneal Opacity
Blindness
Glaucoma
Cataract
Joints
Parents

ASJC Scopus subject areas

  • Rheumatology

Cite this

Therapeutic approaches for ophthalmic problems in juvenile rheumatoid arthritis. / O'Brien, J. M.; Albert, Daniel.

In: Rheumatic Disease Clinics of North America, Vol. 15, No. 3, 01.01.1989, p. 413-437.

Research output: Contribution to journalReview article

@article{247f6ebeea2443508f7bed928eaf1015,
title = "Therapeutic approaches for ophthalmic problems in juvenile rheumatoid arthritis",
abstract = "Juvenile rheumatoid arthritis is a disease of children which is chronic and painful, with the potential to produce permanent disability and blindness in a significant portion of cases. The treatment we provide these children may also disable them. Managing this disease process and caring for these patients is a challenging task in which therapeutic efficacy must be continually balanced against treatment morbidity. With respect to ocular disease, we must particularly recognize the difficulties parents have in treating a characteristically asymptomatic process with interventions that can produce unpleasant symptomatology. The importance of discussion of therapeutic decisions with parent and child cannot be overemphasized. Children with JRA should be carefully classified and those at greatest risk for development of ocular disease should receive frequent ophthalmologic screening exams. Early intervention and aggressive medical management of intraocular inflammation will minimize morbidity and permanent visual compromise. Patients should also be closely monitored for ocular side effects of therapies directed against articular disease. Procedures employed for treatment of cataract, glaucoma, corneal, and vitreal opacities must take into account the risk and complications of surgical intervention in the JRA patient prone to perioperative inflammation.",
author = "O'Brien, {J. M.} and Daniel Albert",
year = "1989",
month = "1",
day = "1",
language = "English (US)",
volume = "15",
pages = "413--437",
journal = "Rheumatic Disease Clinics of North America",
issn = "0889-857X",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Therapeutic approaches for ophthalmic problems in juvenile rheumatoid arthritis

AU - O'Brien, J. M.

AU - Albert, Daniel

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Juvenile rheumatoid arthritis is a disease of children which is chronic and painful, with the potential to produce permanent disability and blindness in a significant portion of cases. The treatment we provide these children may also disable them. Managing this disease process and caring for these patients is a challenging task in which therapeutic efficacy must be continually balanced against treatment morbidity. With respect to ocular disease, we must particularly recognize the difficulties parents have in treating a characteristically asymptomatic process with interventions that can produce unpleasant symptomatology. The importance of discussion of therapeutic decisions with parent and child cannot be overemphasized. Children with JRA should be carefully classified and those at greatest risk for development of ocular disease should receive frequent ophthalmologic screening exams. Early intervention and aggressive medical management of intraocular inflammation will minimize morbidity and permanent visual compromise. Patients should also be closely monitored for ocular side effects of therapies directed against articular disease. Procedures employed for treatment of cataract, glaucoma, corneal, and vitreal opacities must take into account the risk and complications of surgical intervention in the JRA patient prone to perioperative inflammation.

AB - Juvenile rheumatoid arthritis is a disease of children which is chronic and painful, with the potential to produce permanent disability and blindness in a significant portion of cases. The treatment we provide these children may also disable them. Managing this disease process and caring for these patients is a challenging task in which therapeutic efficacy must be continually balanced against treatment morbidity. With respect to ocular disease, we must particularly recognize the difficulties parents have in treating a characteristically asymptomatic process with interventions that can produce unpleasant symptomatology. The importance of discussion of therapeutic decisions with parent and child cannot be overemphasized. Children with JRA should be carefully classified and those at greatest risk for development of ocular disease should receive frequent ophthalmologic screening exams. Early intervention and aggressive medical management of intraocular inflammation will minimize morbidity and permanent visual compromise. Patients should also be closely monitored for ocular side effects of therapies directed against articular disease. Procedures employed for treatment of cataract, glaucoma, corneal, and vitreal opacities must take into account the risk and complications of surgical intervention in the JRA patient prone to perioperative inflammation.

UR - http://www.scopus.com/inward/record.url?scp=0024327643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024327643&partnerID=8YFLogxK

M3 - Review article

C2 - 2672130

AN - SCOPUS:0024327643

VL - 15

SP - 413

EP - 437

JO - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

SN - 0889-857X

IS - 3

ER -